Papel de las grasas esenciales en los procesos inflamatorios asociados a la artritis reumatoide

dc.contributor.authorCarrero, Carmen María
dc.contributor.authorOróstegui, María Alejandra
dc.contributor.authorRuiz Escorcia, Linda
dc.contributor.authorAldana, Edna
dc.date.accessioned2018-10-17T20:29:53Z
dc.date.available2018-10-17T20:29:53Z
dc.date.issued2018
dc.description.abstractLa artritis reumatoidea (AR) corresponde a un complejo desorden autoinmune que se caracteriza por una marcada inflamación y destrucción progresiva de los tejidos que forman las articulaciones. El tratamiento médico está dirigido a la supresión del proceso inflamatorio mitigando así los síntomas y signos de la enfermedad. La intervención nutricional basada en alimentos fuentes de ácidos grasos poliinsaturados (AGPICL ω-3) como: pescados, salmón, trucha, arenque, sardina, atún, anchoas, pez espada actúan como coadyuvantes en el tratamiento de enfermedades de base inflamatoria. El objetivo de este estudio fue analizar la evidencia disponible sobre los efectos terapéuticos de los ácidos grasos poliinsaturados en el estado inflamatorio crónico y en la sintomatología en pacientes con AR. La revisión consistió en la búsqueda bibliográfica en el 2017, con escritos en español o ingles publicados en las bases de datos Medline, Cochrane, Scopus, Sportdiscus y Amed, entre 2001 y 2017. Se demostró que los ácidos grasos esenciales en la artritis reumatoide evidencian reducción del dolor en articulaciones, y/o inflamadas, de la rigidez matutina. Los efectos producidos por el consumo en la alimentación de ácidos grasos esenciales, resulta ser útil como tratamiento de la inflamación aguda y crónica y la disminución de las dosis de AINES.spa
dc.description.abstractRheumatoid arthritis (RA) corresponds to a complex autoimmune disorder characterized by marked inflammation and progressive destruction of the tissues that form the joints. Medical treatment is aimed at suppressing the inflammatory process, thus mitigating the symptoms and signs of the disease. The nutritional intervention based on food sources of polyunsaturated fatty acids (AGPICL ω-3) such as: fish, salmon, trout, herring, sardines, tuna, anchovies, swordfish act as coadjuvants in the treatment of inflammatory-based diseases. The objective of this study was to analyze the available evidence on the therapeutic effects of polyunsaturated fatty acids in the chronic inflammatory state and in the symptomatology in patients with RA. The review consisted of bibliographic search in 2017, with writtings in Spanish or English published in the databases Medline, Cochrane, Scopus, Sportdiscus and Amed, between 2001 and 2017. It was demonstrated that essential fatty acids in rheumatoid arthritis show reduced pain in joints, and/or inflamed, of morning stiffness. The effects produced by the consumption in the feeding of essential fatty acids, it is useful as treatment of acute and chronic inflammation and the decrease of the doses of NSAIDs.eng
dc.identifier.issn26107988
dc.identifier.urihttp://hdl.handle.net/20.500.12442/2319
dc.language.isospaspa
dc.publisherSociedad Venezolana de Farmacología y de Farmacología Clínica y Terapéuticaspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.licenseLicencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacionalspa
dc.sourceArchivos Venezolanos de Farmacología y Terapéuticaspa
dc.sourceVol. 37, No. 3 (2018)spa
dc.source.urihttp://www.revistaavft.com/images/revistas/2018/avft_3_2018/20_papel_grasas_esenciales.pdfspa
dc.subjectÁcidos Grasosspa
dc.subjectArtritis Reumatoidespa
dc.subjectProcesos Inflamatoriosspa
dc.subjectFatty acidseng
dc.subjectRheumatoid arthritiseng
dc.subjectInflammatory Processeseng
dc.titlePapel de las grasas esenciales en los procesos inflamatorios asociados a la artritis reumatoidespa
dc.typearticlespa
dcterms.referencesFauci AS. Langford CA. Harrison Reumatología. [Internet]. 16a ed. Madrid: McGraw-Hill-Interamericana; 2007; Disponible en: https://scholar.google.com/scholar_lookup?title=+Harrison+Reumatolog%C3 %ADa&author=Fauci+AS.&author=Langford+CA&publication_year=2007eng
dcterms.referencesSociedad Española de Reumatología. Manual SER de las Enfermedades Reumáticas. [Internet]. 2004; 4a ed. Madrid: Editorial Médica Panamericana. Disponible en: https://scholar.google.com/scholar_lookup?title=+Manual+SER+de+las+Enfe rmedades+Reum%C3%A1ticas&publication_year=2004spa
dcterms.referencesCarmona L, Gabrielb R, Ballinac J, Laffond A, y Grupo de Estudio EPISER* Proyecto EPISER 2000: Prevalencia de enfermedades reumáticas en la población española. Metodología, resultados del reclutamiento y características de la población 2001; Rev Esp Reumatol; 28:18-25.spa
dcterms.referencesSpindler A, Bellomio V, Berman A, Lucero E, Baigorria M, Paz S, et al. Prevalence of rheumatoid arthritis in Tucumán, Argentina. J Rheumatol. 2002; 29:1166–70.eng
dcterms.referencesScublinsky D, Venarotti H, Citera G, Messina OD, Scheines E, Rillo O. The prevalence of rheumatoid arthritis in argentina: a capture-recapture study in a city in Buenos Aires province.2010; J Clin Rheumatol; 16:317–21.eng
dcterms.referencesCordeiro de Azevedo A B, Ferraz, Marco Ciconelli R. Indirect Cost of Rheumatoid Arthritis in Brazil.2008; Value Health. Sep-Oct;11(5):869-77.eng
dcterms.referencesBurgos-Vargas R, Current Therapies in Rheumatoid artritis: A Latin America Perspective.2013; Reumatol Clin; 09:106-12. - vol.09 núm 02.eng
dcterms.referencesRamos-Remus C, Sierra-Jimenez G, Skeith K, Aceves-Avila FJ, Russell AS, Offer R. Latitude gradient influences the age of onset of rheumatoid artritis patients. 2007; Clin Rheumatol; 26:1725–8.eng
dcterms.referencesCombe B. Early rheumatoid arthritis: strategies for prevention and management.2007; Best Pract Res Clin Rheumatol.; 21:27-42.eng
dcterms.referencesCaballero-Uribe C, Wilches H, Wilches K, Rojas J, Salas Siado J, Forero E. Utilización de medicinas alternativas en la consulta reumatológica en la ciudad de Barranquilla.2002; Rev Col Rheumatol; 9:194–200.spa
dcterms.referencesMesa M D, Aguilera C M, Gil A. Importance of lipids in the nutritional treatment of inflammatory diseases.2006; Nutr Hosp; 21 (Suppl. 2): 28-41, 30-43eng
dcterms.references. Calder P C, Albers R, Antoine J-, Blum S, Bourdet-Sicard R, Ferns G A. Inflammatory disease processes and interactions with nutrition. 2009; Br J Nutr; 101 (Suppl. S1): S1-S45eng
dcterms.referencesGalarraga B, Ho M, Youssef HM, Hill A, McMahon H, Hall C. Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis.2008; Rheumatology (Oxford); 47(5):665-9.eng
dcterms.references. Miles E A, Calder P C. Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis.2012; Br J Nutr; 107(Suppl. 2):S171-84eng
dcterms.referencesWall R, Ross R P, Fitzgerald G F, Stanton C. Fatty acids from fish: The antiinflammatory potential of long-chain omega-3 fatty acids.2010; Nutr Rev; 68(5):280-9.eng
dcterms.referencesJames M, Proudman S, Cleland L. Fish oil and rheumatoid arthritis: past, present and future.2010; Proc Nutr Soc; 69(3):316-23.eng
dcterms.referencesGallego Águila A. Intervención alimentaria en la artritis reumatoide.2015; Universidad de Jaén Facultad de Ciencias de la Salud: Tesis de grado.spa
dcterms.referencesUchiyama K, Nakamura M, Odahara S, Koido S, Katahira K, Shiraishi H. Polyunsaturated fatty acid diet therapy for patients with inflammatory bowel disease. Inflamm Bowel Dis 2010; 16:1696-707.eng
dcterms.referencesParameswaran N, Patial S. 2010. Tumor necrosis factor-α signaling in macrophages. Crit Rev Eukaryot Gene Expr; 20:87-103.eng
dcterms.referencesMcInnes I B, O’Dell J R. State of the art: rheumatoid arthritis.2011; Ann Rheum Diseases. 2011; 70 399-399 69:1898-906.eng
dcterms.referencesScott D L, Wolfe F, Huizinga T W. Rheumatoid arthritis. 2010. Lancet.25: 1094- 108.eng
dcterms.referencesBahadori B, Uitz E, Thonhofer R, Trummer M, Pestemer-Lach I, McCarty M, Krejs G J. Omega-3 Fatty acids infusions as adjuvant therapy in rheumatoid arthritis.2010; JPEN J Parenter Enteral Nutr .34:151-5.eng
dcterms.referencesHurst S, Zainal Z, Caterson B, Hughes CE, Harwood JL. Dietary fatty acids and arthritis. Prostaglandins Leukot Essent Fatty Acids, 2010;82:315-8.eng
dcterms.referencesDawczynski C, Schubert R, Hein G, Müller A, Eidner T, Vogelsang H, Basu S, Jahreis G. Long-term moderate intervention with n-3 long-chain PUFA-supplemented dairy products: effects on pathophysiological biomarkers in patients with rheumatoid arthritis. 2009; Br J Nutr .101:1517-26.eng
dcterms.referencesGalarraga B, Ho M, Youssef H M, Hill A, McMahon H, Hall.Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis.2008; Rheumatology (Oxford). 47:665-9.eng
dcterms.referencesBurr GO, Burr MM. On the nature and role of the fatty acids essential in nutrition. J. Biol. Chem. 1930. 86, 587–62. Disponible en: http://www.jbc.org/content/86/2/587.shorteng
dcterms.referencesPorrata Maury C, Ruiz Álvarez V, Hernández Triana M. Alimentación y Nutrición en niños y adolescentes con enfermedades autoinmunes. [accessed Sep 10, 2017].Cap 41 O/p: 543-545. (pdf Download Availables from:https:// www.researchgate.net/publication/258763549spa
dcterms.referencesMenza. V, Probart. C. Organización de las Naciones Unidas para la Alimentación y la Agricultura, Roma, 2013. Alimentarnos bien para estar sanos Lecciones sobre nutrición y alimentación saludable Pp 88-89.spa
dcterms.referencesValenzuela R, Tapia G, González M, Valenzuela A. Ácidos Grasos Omega-3 (EPA Y DHA) y su aplicación en diversas situaciones clinicas.2011; Rev Chil Nutr Vol. 38, N°3, Pp.: 356-367spa
dcterms.referencesRatnayake W M, Galli C. Fat and Fatty Acid Terminology, Methods of Análisys and Fat Digestion and Metabolism: A Background Review Paper.2009; Ann Nutr Metab.55:8-43.eng
dcterms.referencesCarbajal A. Ingestas recomendadas de energía y nutrientes.2013; (ISBN: 84- 9773-023-2).spa
dcterms.referencesFauci A S, Langford C A. Harrison.Reumatología.2007; 16a ed. McGraw-HillInteramericana.eng
dcterms.referencesCalder P C. Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on ‘Nutrition and autoimmune disease’ PUFA, inflammatory processes and rheumatoid arthritis.2008; Proc Nutr Soc; 67(4):409-18eng
dcterms.referencesCaughey G E, James M J, Proudman S M, Cleland L G. Fish oil supplementation increases the cyclooxygenase inhibitory activity of paracetamol in rheumatoid arthritis patients.2010; Complement Ther Med; 18(3-4):171-4.eng
dcterms.referencesYacoubian S, Serhan C N. New endogenous anti-inflammatory and proresolving lipid mediators: Implications for rheumatic diseases. 2007; Nature Clinical Practice Rheumatology; 3(10):570-9.eng
dcterms.referencesMoghaddami N, Irvine J, Gao X, Grover PK, Costabile M, Hii C S. Action of n-3 polyunsaturated fatty acids: Inhibition of arachidonic acid-induced increase in tumor necrosis factor receptor expression on neutrophils and a role for proteases. 2007; Arthritis Rheum; 56(3):799-808.eng
dcterms.referencesRemans P H, Sint J K, Wagenaar L W, Wouters-Wesseling W, Zuijderduin W M, Jongma A. Nutrient supplementation with polyunsaturated fatty acids and micronutrients in rheumatoid arthritis: clinical and biochemical effects.2004; Eur J Clin Nutr; 58(6):839-45.eng
dcterms.referencesOh R. Practical applications of fish oil (Omega-3 fatty acids) in primary care. 2005; J Am Board Fam Pract; 18(1):28-36.eng
dcterms.referencesDawczynski C, Schubert R, Hein G, Muller A, Eidner T, Vogelsang H. Longterm moderate intervention with n-3 long-chain PUFA-supplemented dairy products: effects on pathophysiological biomarkers in patients with rheumatoid arthritis. 2009; Br JNutr; 101(10):1517-26eng
dcterms.referencesDarlington L G, Stone T W. Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders.2001; BR J Nutr. 85: 251-269.eng
dcterms.referencesGoldberg R J, Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. 2007; Pain; 129(1-2):210-23eng
dcterms.referencesLee H, Surh Y. Therapeutic potential of resolvins in the prevention and treatment of inflammatory disorders. 2012; Biochem Pharmacol; 84(10):1340-50.eng
dcterms.referencesSidhu K S. Health benefits and potential risks related to consumption of fish or fish oil. Regulatory Toxicology and Pharmacology. 2003; 38(3):336-44.eng
dcterms.referencesHayashi H, Satoi K, Sato-Mito N, Kaburagi T, Yoshino H, Higaki M. Nutritional status in relation to adipokines and oxidative stress is associated with disease activity in patients with rheumatoid arthritis.2012; Nutrition; 28(11-12):1109-14.eng
dcterms.referencesBerbert A A, Kondo C R M, Almendra C L, Matsuo T, Dichi I. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis.2005; Nutrition; 21(2):131-6.eng
dcterms.referencesCovington M B. Omega-3 fatty acids. 2004; Am Fam Physician; 70(1):133-40.eng
dcterms.referencesCleland L G, James M J, Proudman S M. 2006. Fish oil: What the prescriber needs to know. Arthritis Research and Therapy; 8(1):202eng
dcterms.referencesStamp L K, James M J, Cleland L G. Diet and rheumatoid arthritis: a review of the literature. 2005; Semin Arthritis Rheum; 35 (2): 77-94.eng
dcterms.referencesSkoldstam L, Hagfors L, Johansson G. An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis. 2003; Ann Rheum Dis; 62(3):208-14.eng
dcterms.referencesLucas L, Russell A, Keast R. Molecular mechanisms of inflammation. Antiinflammatory benefits of virgin olive oil and the phenolic compound oleocanthal.2011; Curr Pharm Des; 17(8):754-68. 6eng
dcterms.referencesWaterman E, Lockwood B. Active components and clinical applications of olive oil.2007; Alternative Medicine Review; 12(4):331-42.eng
dcterms.referencesGalli C, Calder P C. Effects of fat and fatty acid intake on inflammatory and immune responses: a critical review. 2009; Ann Nutr Metab; 55(1-3):123-39.eng
dcterms.referencesTripoli E, Giammanco M, Tabacchi G, Di Majo D, Giammanco S, La Guardia M. The phenolic compounds of olive oil: Structure, biological activity and beneficial effects on human health.2005; Nutrition Research Reviews; 18(1):98-112eng
dcterms.referencesLiang X, Wang Q, Shi J, Lokteva L, Breyer RM, Montine TJ. The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis.2008; Ann Neurol; 64(3):304eng
dcterms.referencesCruz-Chamorro L, Puertollano M A, Puertollano E, Álvarez de Cienfuegos G, De Pablo M A. Examination of host immune resistance against Listeria monocytogenes infection in cyclophosphamide-treated mice after dietary lipid administration. 2007; Clin Nutr; 26:631-9.eng
dcterms.referencesMiles E A, Zoubouli P, Calder P C. Differential anti-inflammatory effects of phenolic compounds from extra virgin olive oil identified in human whole blood cultures.2005; Nutrition; 21:389-94.eng
dcterms.referencesBeauchamp G K, Keast R S, Morel D, Lin J, Pika J, Han Q, Lee C H, Smith A B, Breslin P A. Phytochemistry: Ibuprofen-like activity in extra-virgin olive oil. 2005; Nature; 437:45-6.eng
dcterms.referencesPuertollano M A, Puertollano E, Ruiz-Bravo A, Jiménez-Valera M, De Pablo M A, De Cienfuegos G A. Changes in the immune functions and susceptibility to Listeria monocytogenes infection in mice fed dietary lipids. 2004; Immunol Cell Biol; 82:370-6.eng
dcterms.referencesKarlson E W, Shadick N A, Cook N R, Buring J E, Lee I M. Vitamin E in the primary prevention of rheumatoid arthritis: the Women’s Health Study.2008; Arthritis Rheum.15; 59(11):1589-95.eng
dcterms.referencesLahiri M, Morgan C, Symmons D P, Bruce I N. Modifiable risk factors for RA: prevention, better than cure. 2012; Rheumatology (Oxford); 51(3):499-512.eng
dcterms.referencesCerhan J R, Saag K G, Merlino L A, Mikuls T R, Criswell L A. Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women. 2003; Am J Epidemiol. 15; 157(4):345-54.eng
dcterms.referencesKnekt P, Heliövaara M, Aho K, Alfthan G, Marniemi J, Aromaa A. Serum selenium, serum alpha-tocopherol, and the risk of rheumatoid arthritis. 2000; Epidemiology; 11(4):402-5.eng
dcterms.referencesBae S C, Jung W J, Lee E J, Yu R, Sung M K. Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients. 2009; J Am Coll Nutr; 28(1):56-62.eng
dcterms.referencesDe La Cruz J, Wayne Dyzinger, S, Dos Dantos F, Villegas H, Ezinga M. Medicina del Estilo de Vida: trabajando juntos para revertir la epidemia de las enfermedades crónicas en Latinoamérica. DIc 2017. Cienc innov salud. 4(2):1-7 DOI 10.17081/innosa. 4.2.2870.spa

Archivos

Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
368 B
Formato:
Item-specific license agreed upon to submission
Descripción:

Colecciones